Dr. Lieping Chen, newly appointed as the United Technologies Corporation Professor in Cancer Research, focuses his research on developing new treatment options for cancer. His laboratory discovered the B7-H1/PD-1 immune inhibitory pathway and established...
Dr. Roy S. Herbst, recently designated as the Ensign Professor of Medical Oncology, is nationally recognized for his leadership and expertise in lung cancer treatment and research. His primary mission is the enhanced integration of clinical, laboratory,...